A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults
A Phase 3, Randomized, Double‑Blind, Placebo‑Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Zavegepant Intranasal (IN) for the Acute Treatment of Migraine in Asian Adults
Category & Conditions: Respiratory Disease
Medicine: ZAVZPRET™(ZAVEGEPANT)
ClinicalTrials.gov Identifier (NCT): NCT05989048
Protocol ID: C5301008
Open Plain Language Summary Result:
Click here